Company intelligence / Profile preview

Biolie

Saint Ouen l'Aumône, Île-de-France, Francebiolie.fr ↗

Ownership: Private
Development stage: Commercial

Overview

Biolie developed and commercialized a patented solvent-free enzymatic extraction technology to produce natural active ingredients from plants. Their actives have demonstrated benefits such as antioxidant activity, anti-aging effects, skin cell protection from pollution, collagen boosting, and DNA preservation in laboratory tests. The company was acquired by Sensient Technologies in early 2025.

Industry: Non-Drug Biotech

Partnerships

Sensient Beauty/Sensient Technologies

Beyond the preview

Go deeper on Biolie.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biolie.

Explore the full profile